{"name":"Johnson & Johnson Development Corporation","permalink":"johnson-johnson-development-corporation","crunchbase_url":"http://www.crunchbase.com/financial-organization/johnson-johnson-development-corporation","homepage_url":"http://www.jjdevcorp.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"(732) 524-3218","description":"venture capital","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Jun 22 19:58:06 UTC 2009","updated_at":"Tue Sep 01 11:54:35 UTC 2009","overview":"<p>Johnson &amp; Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson &amp; Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investmentâ€™s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson &amp; Johnson.</p>","image":{"available_sizes":[[[150,57],"assets/images/resized/0005/8402/58402v1-max-150x150.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-250x250.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"HQ","address1":"410 George Street","address2":"","zip_code":"08901","city":"New Brunswick","state_code":"NJ","country_code":"USA","latitude":40.496864,"longitude":-74.444464}],"relationships":[],"investments":[{"funding_round":{"round_code":"d","source_url":"http://www.mitsuiventures.com/en/investment/news/2008/20081006.html","source_description":"Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of LocteronÂ® in Hepatitis C","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":6,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/press-releases/catalyst-biosciences-raises-40-million-series-c-financing?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB","source_description":"Catalyst Biosciences Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":3,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/coaxia-inc-series-d-215m/","source_description":"CoAxia, Inc.: Series D $21.5M","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":24,"company":{"name":"CoAxia","permalink":"coaxia","image":{"available_sizes":[[[150,73],"assets/images/resized/0005/0539/50539v1-max-150x150.png"],[[211,104],"assets/images/resized/0005/0539/50539v1-max-250x250.png"],[[211,104],"assets/images/resized/0005/0539/50539v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/neotract-inc-series-b-237m/","source_description":"Neotract, Inc.: Series B $23.7M","raised_amount":23700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"company":{"name":"Neotract","permalink":"neotract","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.neurosearch.com/Default.aspx?ID=3&M=News&PID=91&NewsID=15792","source_description":"NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV ","raised_amount":14330000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":17,"company":{"name":"Neurosearch","permalink":"neurosearch","image":{"available_sizes":[[[129,17],"assets/images/resized/0006/0984/60984v1-max-150x150.png"],[[129,17],"assets/images/resized/0006/0984/60984v1-max-250x250.png"],[[129,17],"assets/images/resized/0006/0984/60984v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.Metabolex.com/news/apr192007.html","source_description":"Metabolex","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":19,"company":{"name":"Metabolex","permalink":"metabolex","image":{"available_sizes":[[[150,23],"assets/images/resized/0006/5572/65572v1-max-150x150.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-250x250.jpg"],[[171,27],"assets/images/resized/0006/5572/65572v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.pronota.com/?top=news&sub=press-releases&date=19042006","source_description":"Pronota","raised_amount":7800000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":19,"company":{"name":"Pronota","permalink":"pronota","image":{"available_sizes":[[[140,90],"assets/images/resized/0006/7923/67923v1-max-150x150.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-250x250.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pronota.com/?top=news&sub=press-releases&date=29062009","source_description":"Pronota","raised_amount":7360000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":29,"company":{"name":"Pronota","permalink":"pronota","image":{"available_sizes":[[[140,90],"assets/images/resized/0006/7923/67923v1-max-150x150.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-250x250.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.novocell.com/news/press/2007-07-16.html","source_description":"Novocell Raises $25 Million","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":16,"company":{"name":"Novocell","permalink":"novocell","image":{"available_sizes":[[[150,61],"assets/images/resized/0008/0091/80091v1-max-150x150.jpg"],[[165,68],"assets/images/resized/0008/0091/80091v1-max-250x250.jpg"],[[165,68],"assets/images/resized/0008/0091/80091v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.molecularpartners.com/cnt_press.php?pres=14","source_description":"MOLECULAR PARTNERS SECURES $15.56 million IN SERIES A FINANCING","raised_amount":15560000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":14,"company":{"name":"Molecular Partners","permalink":"molecular-partners","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/0288/70288v1-max-150x150.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-250x250.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":3,"company":{"name":"Novocell","permalink":"novocell","image":{"available_sizes":[[[150,61],"assets/images/resized/0008/0091/80091v1-max-150x150.jpg"],[[165,68],"assets/images/resized/0008/0091/80091v1-max-250x250.jpg"],[[165,68],"assets/images/resized/0008/0091/80091v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/astute-medical-inc-series-b-265m/","source_description":"Astute Medical, Inc.: Series B $26.5M","raised_amount":26500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":12,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/breathe-technologies-inc-series-c-23m/","source_description":"Breathe Technologies, Inc.: Series C $23M","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":20,"company":{"name":"Breathe Technologies","permalink":"breathe-technologies","image":{"available_sizes":[[[150,65],"assets/images/resized/0005/1250/51250v1-max-150x150.jpg"],[[203,89],"assets/images/resized/0005/1250/51250v1-max-250x250.jpg"],[[203,89],"assets/images/resized/0005/1250/51250v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.sec.gov/Archives/edgar/vprr/09/9999999997-09-005476","source_description":"SEC","raised_amount":5450000,"raised_currency_code":"USD","funded_year":2009,"funded_month":2,"funded_day":21,"company":{"name":"ImaCor","permalink":"imacor","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://phx.corporate-ir.net/phoenix.zhtml?c=218965&p=irol-newsArticle&ID=1431504&highlight=","source_description":"Tengion Inc. Completes $39 Million Series \"A\" Round Financing Will Advance Development of Regenerative Medicine Products","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":3,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://biolex.com/pdfs/Biolex%20Raises%20$36M.pdf","source_description":"BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING","raised_amount":36000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":9,"funded_day":1,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":1,"funded_day":7,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biocartis.com/cms/index.php?page=news","source_description":"Biocartis raises â‚¬30 million in Series â€˜B' financing round","raised_amount":41300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":8,"company":{"name":"Biocartis","permalink":"biocartis","image":{"available_sizes":[[[150,44],"assets/images/resized/0017/3531/173531v1-max-150x150.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-250x250.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://techcrunch.com/2010/11/09/23andme-funding-2/","source_description":"Personal Genetics Startup 23andMe Raises $22 Million More From Google, Others","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":9,"company":{"name":"23andMe","permalink":"23andme","image":{"available_sizes":[[[105,72],"assets/images/resized/0000/1291/1291v3-max-150x150.png"],[[105,72],"assets/images/resized/0000/1291/1291v3-max-250x250.png"],[[105,72],"assets/images/resized/0000/1291/1291v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20110308&ID=13111899&topic=TOPIC_FINANCING&isub=1","source_description":"Astute Medical Completes $13 Million Financing With Existing Stockholders","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":8,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/07/nevro-completes-58m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Nevro Completes $58M Financing","raised_amount":58000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":19,"company":{"name":"Nevro","permalink":"nevro","image":{"available_sizes":[[[135,85],"assets/images/resized/0012/6898/126898v1-max-150x150.jpg"],[[135,85],"assets/images/resized/0012/6898/126898v1-max-250x250.jpg"],[[135,85],"assets/images/resized/0012/6898/126898v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/11/biocartis-completes-e71m-series-equity-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Biocartis Completes â‚¬71M Series C Equity Funding","raised_amount":71000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":11,"funded_day":17,"company":{"name":"Biocartis","permalink":"biocartis","image":{"available_sizes":[[[150,44],"assets/images/resized/0017/3531/173531v1-max-150x150.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-250x250.png"],[[176,52],"assets/images/resized/0017/3531/173531v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/02/celladon-closes-43m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Celladon Closes $43M in Funding","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":15,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/05/mitralign-closes-35m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mitralign Closes $35M in Series D Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":16,"company":{"name":"Mitralign","permalink":"mitralign","image":{"available_sizes":[[[150,63],"assets/images/resized/0019/0150/190150v1-max-150x150.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-250x250.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120605e865tt70p&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865tt70p%26from%3dalert%26pid%3d32","source_description":"PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B ","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/astute-medical-completes-40-4m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Astute Medical Completes $40.4M Series C Financing","raised_amount":40400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":7,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.masshightech.com/stories/2012/10/08/daily28-Genocea-raises-30M-to-advance-herpes-vaccine.html","source_description":"Genocea raises $30M to advance herpes vaccine","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":10,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}